Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 050 538.3 |
96 | EP file number | EAKZ | 14 18 8334.8 |
97 | EP publication number | EPN | 2868315 |
54 | Designation/title | TI | VERBESSERTE FORMULIERUNGEN UND VERFAHREN ZUR LYOPHILISIERUNG UND DAMIT BEREITGESTELLTE LYOPHILISATE |
51 | IPC main class | ICM (ICMV) | A61K 9/16 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/20 (2006.01), A61K 31/175 (2006.01) |
22 | DE application date | DAT | Dec 3, 2008 |
96 | EP application date | EAT | Dec 3, 2008 |
43 | Date of first publication | OT | May 6, 2015 |
| Date of publication of grant | PET | May 31, 2017 |
71/73 | Applicant/owner | INH | Remedy Pharmaceuticals, Inc., New York, NY, US |
72 | Inventor | IN | Jacobson, Martin, Sven, New York, NY New York 10001, US |
74 | Representative | VTR | Stolmár & Partner Patentanwälte PartG mbB, 80331 München, DE |
| Address for service | | Stolmár & Partner Patentanwälte PartG mbB, 80331 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 992241 P Dec 4, 2007
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002868315 Searchable text:
EP000002868315 Original document:
EP000002868315B1 Searchable text:
EP000002868315B1 |
43 | Date of first publication | EVT | May 6, 2015 |
| Date of the first transfer into DPMAregister | EREGT | May 7, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 30, 2024 (Show all update days)(Hide all update days)- Nov 30, 2024
- May 7, 2015
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 5, 2024 |
| Issue number | HN | 28 |
| Year | PJ | 2024 |
| Publication date | VT | Jul 11, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Remedy Pharmaceuticals, Inc., New York, NY, US |
71/73 | Previous applicant/owner | INHF | Biogen Chesapeake LLC, Cambridge, Mass., US |
| Date of update of the procedure | REGT | Jul 11, 2024 |